PR Newswire Clinical TrialsOriginal article
Memorial Cancer Institute among first in South Florida to acquire breakthrough drug to treat pancreatic cancer
RegulatoryapproveddaraxonrasibPositive
AI Analysis
Summary
Memorial Cancer Institute became the first cancer program in Broward County, Florida to obtain daraxonrasib, described as a breakthrough drug representing a significant advance in pancreatic cancer treatment.
Outcome Details
Breakthrough drug acquired by Memorial Cancer Institute for pancreatic cancer treatment
Importance:5/10
Sentiment:
0.70
pancreatic cancerbreakthrough therapydrug acquisitiononcology
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 31, 2026 5:04 PM